Farrell v CSL Ltd

In the Federal Court of Australia, the case of Farrell v CSL Ltd involved a plaintiff who alleged that he had suffered psychiatric injury due to the defendant's failure to adequately inform him of the risks associated with receiving human pituitary gonadotrophin treatment, which he underwent in 1984. The plaintiff later developed Creutzfeldt-Jakob Disease (CJD), a rare and fatal neurodegenerative disorder, and claimed that this disease was linked to his treatment. The primary issues before the court were whether the defendant owed the plaintiff a duty of care in relation to the risk of contracting CJD and whether this duty, if found, was breached, resulting in the plaintiff's psychiatric injury.

The court considered the principles of duty of care in tort law, particularly in the context of medical treatment and the communication of risks to patients. It examined whether the defendant, as a medical provider, had a duty to inform the plaintiff of the potential long-term risks of contracting CJD from the treatment. The court also evaluated the foreseeability of the plaintiff's psychiatric injury and whether there was a sufficient proximate relationship between the defendant's actions and the injury. Additionally, the court assessed whether the plaintiff's fiduciary relationship with the defendant, if any, had any relevance to his personal injury claim.

The court concluded that the defendant did owe the plaintiff a duty of care concerning the risk of contracting CJD, which was a foreseeable consequence of the treatment. It held that the defendant breached this duty by not adequately communicating the risks to the plaintiff. The court found that the plaintiff's psychiatric injury was a direct result of this breach, as he developed CJD and attributed his condition to the treatment he received. Therefore, the court ruled in favour of the plaintiff on the basis of negligence. The court ordered the defendant to compensate the plaintiff for his psychiatric injury and any other consequential losses.